SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-002290
Filing Date
2019-01-22
Accepted
2019-01-22 16:46:15
Documents
7
Period of Report
2019-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv511350_8k.htm 8-K 32630
2 EXHIBIT 4.1 tv511350_ex4-1.htm EX-4.1 97387
3 EXHIBIT 5.1 tv511350_ex5-1.htm EX-5.1 8429
4 EXHIBIT 10.1 tv511350_ex10-1.htm EX-10.1 225872
5 EXHIBIT 99.2 tv511350_ex99-2.htm EX-99.2 11239
6 GRAPHIC tv511350_ex5-1img1.jpg GRAPHIC 12329
7 GRAPHIC tv511350_ex99-2img2.jpg GRAPHIC 16610
  Complete submission text file 0001144204-19-002290.txt   417052
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 19535762
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1